Robert F. Padera

Active 1996–2025

118
Papers
28,565
Citations
85
h-index
116
i10-index

Citations

Citations per year for Robert F. Padera1958: 1 citations1993: 1 citations1997: 2 citations1998: 3 citations1999: 11 citations2000: 17 citations2001: 18 citations2002: 36 citations2003: 56 citations2004: 67 citations2005: 68 citations2006: 82 citations2007: 126 citations2008: 171 citations2009: 223 citations2010: 275 citations2011: 322 citations2012: 299 citations2013: 298 citations2014: 317 citations2015: 320 citations2016: 301 citations2017: 259 citations2018: 243 citations2019: 815 citations2020: 1,144 citations2021: 1,644 citations2022: 1,301 citations2023: 792 citations2024: 1,035 citations2025: 482 citations2026: 16 citations1959–1992: no citations, so these years are not shown1994–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,802 citing papers, 29.7% of this breakdownChina: 2,019 citing papers, 12.5% of this breakdownUnited Kingdom: 986 citing papers, 6.1% of this breakdownGermany: 774 citing papers, 4.8% of this breakdownItaly: 706 citing papers, 4.4% of this breakdownFrance: 518 citing papers, 3.2% of this breakdownCanada: 517 citing papers, 3.2% of this breakdownJapan: 492 citing papers, 3% of this breakdownSpain: 388 citing papers, 2.4% of this breakdownAustralia: 384 citing papers, 2.4% of this breakdownNetherlands: 351 citing papers, 2.2% of this breakdownSwitzerland: 350 citing papers, 2.1% of this breakdown
0%29.7%Other 24%

Fields

  • Medicine60.6%
  • Biochemistry, Genetics and Molecular Biology19.9%
  • Engineering5.5%
  • Immunology and Microbiology5.5%
  • Materials Science4.4%
  • Neuroscience1.2%
  • Other2.9%

Topics

  • COVID-19 Clinical Research Studies3.7%
  • SARS-CoV-2 and COVID-19 Research3.6%
  • Lung Cancer Treatments and Mutations3.3%
  • Long-Term Effects of COVID-192.6%
  • Cancer Immunotherapy and Biomarkers2.6%
  • PI3K/AKT/mTOR signaling in cancer1.4%
  • Other82.8%

Coauthors

All papers

Open in search
  1. Dry double-sided tape for adhesion of wet tissues and devices

    Authors: , , , , , , - Nature 2019 cited by 1,458

  2. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Malika Sud, Victoria M. Tran, Shamsudheen Karuthedath Vellarikkal, Yiping Wang, Liat Amir-Zilberstein, Deepak Atri, Joseph Beechem, Olga R. Brook, Jonathan Chen, Prajan Divakar, Phylicia Dorceus, J Engreitz, Adam L. Essene, Donna M. Fitzgerald, Robin Fropf, Steven Gazal, Joshua Gould, John Grzyb, Tyler Harvey, Jonathan L. Hecht, Tyler Hether, Judit Jané‐Valbuena, Michael Leney-Greene, Hui Ma, Cristin McCabe, Daniel E. McLoughlin, Eric Miller, Christoph Muus, Mari Niemi, Robert F. Padera, Liuliu Pan, Deepti Pant, Carmel Pe’er, Jenna Pfiffner-Borges, Christopher J. Pinto, Jacob Plaisted, Jason Reeves, Marty Ross, Melissa A. Rudy, Erroll H. Rueckert, Michelle Siciliano, Alexander Sturm, Ellen Todres, Avinash Waghray, Sarah Warren, Shuting Zhang, Daniel R. Zollinger, Lisa A. Cosimi, Rajat M. Gupta, Nir Hacohen, Hanina Hibshoosh, Winston Hide, Alkes L. Price, Jayaraj Rajagopal, Purushothama Rao Tata, Stefan Riedel, Gyöngyi Szabó, Timothy L. Tickle, Patrick T. Ellinor, Deborah T. Hung, Pardis C. Sabeti, Richard Novák, Robert Rogers, Donald E. Ingber, Z. Gordon Jiang, Dejan Juric, Mehrtash Babadi, Samouil L. Farhi, Benjamin Izar, James R. Stone and 9 more - Nature 2021 cited by 883

  3. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 454

  4. Cardiovascular toxicities associated with immune checkpoint inhibitors

    Authors: , , , , , , , , , - Cardiovascular Research 2019 cited by 506

  5. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Manuela Cernadas, Jonathan Z. Li - New England Journal of Medicine 2020 cited by 1,383

  6. Cartilage-penetrating nanocarriers improve delivery and efficacy of growth factor treatment of osteoarthritis

    Authors: , , , , - Science Translational Medicine 2018 cited by 319

  7. Myocarditis in the Setting of Cancer Therapeutics

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2019 cited by 445

  8. BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

    Authors: , , , , , , , , , , , , , , - Oncogene 2008 cited by 1,442

  9. LKB1 modulates lung cancer differentiation and metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diego H. Castrillón, Nabeel Bardeesy, Norman E. Sharpless, Kwok‐Kin Wong - Nature 2007 cited by 1,079

  10. Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis

    Authors: , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 700

  11. Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

    Authors: , , , , , , , , , , , , , , - Nature 2009 cited by 999

  12. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ngoc L. Ly, Ashlin R. Michell, Yelizaveta Rassadkina, Kyra Seiger, Libera Sessa, Sally Shin, Nishant K. Singh, Weiwei Sun, Xiaoming Sun, Hannah Ticheli, Michael T. Waring, Alex Zhu, Galit Alter, Jonathan Z. Li, Daniel Lingwood, Aaron G. Schmidt, Mathias Lichterfeld, Bruce D. Walker, Xu G. Yu, Robert F. Padera, Shiv Pillai - Cell 2020 cited by 784

  13. Neuropathological Features of Covid-19

    Authors: , , , , , , , , , - New England Journal of Medicine 2020 cited by 846

  14. A Blood-Resistant Surgical Glue for Minimally Invasive Repair of Vessels and Heart Defects

    Authors: , , , , , , , , , , , , , , , , - Science Translational Medicine 2014 cited by 314

  15. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial

    Authors: , , , , , , , , , , , - The Lancet 2015 cited by 540

  16. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 cited by 997

  17. Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis

    Authors: , , , , , , , , , - JACC Heart Failure 2014 cited by 244

  18. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2008 cited by 1,330

  19. Extrafollicular IgD−CD27−CXCR5−CD11c− DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2023 cited by 48

  20. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015

    Authors: , , , , , , , , , , , - JAMA Cardiology 2018 cited by 124

  21. K-ras activation generates an inflammatory response in lung tumors

    Authors: , , , , , , , , , , , , , , , - Oncogene 2005 cited by 267

  22. Prolongation of sciatic nerve blockade by in situ cross-linked hyaluronic acid

    Authors: , , , , - Biomaterials 2004 cited by 189

  23. Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2014 cited by 392

  24. Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy

    Authors: , , , , , , , , - Circulation 2010 cited by 168